Relief Therapeutics Holding AG (RLFTF)

[tcm55]

Is it possible that RLF.SW makes an end run around NRX and applied for EMA accelerated assessment for RLF-100.?.
The disease is increasing most in Central Europe.

Relief is a Swiss company while NRX is US/Israel based and may be applying for FDA EUA for RLF-100. 50%-50% revenue split.

The EAP and Phase 2b/3 data have been received by RLF. Their AO is the rest of the World. IMO it would be their responsibility to do any applications and sales in those Areas of Operation.. 80%-20% revenue split...GLTA...